|
|
||||||||
Sign In to gain access to subscriptions and/or personal tools. |
|||||||||
Articles |
Sixty volunteers were endoscopically evaluated to compare gastric mucosal injury following oral administration of sulindac, naproxen, aspirin, or placebo for two consecutive seven-day periods. A single-blind technique was utilized wherein the endoscopist was unaware which drug each volunteer had received. The following dosages were employed for the two study periods: sulindac, 150 and 200 mg, b.i.d., naproxen, 250 and 375 mg, b.i.d., and aspirin, 650 and 975 mg, q.i.d. The only subject who developed a frank ulcer with mucosal bleeding was in the sulindac group, however volunteers taking sulindac demonstrated statistically less significant mucosal injury on endoscopic examination than those receiving naproxen or aspirin.
This article has been cited by other articles:
![]() |
S. E. Rubesin, M. S. Levine, and I. Laufer Double-Contrast Upper Gastrointestinal Radiography: A Pattern Approach for Diseases of the Stomach Radiology, January 1, 2008; 246(1): 33 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Uppal, S. K. Lateef, M. A. Korsten, F. Paronetto, and C. S. Lieber Chronic Alcoholic Gastritis: Roles of Alcohol and Helicobacter pylori Arch Intern Med, April 1, 1991; 151(4): 760 - 764. [Abstract] [PDF] |
||||
![]() |
D. Y. GRAHAM and J. L. SMITH Aspirin and the Stomach Ann Intern Med, March 1, 1986; 104(3): 390 - 398. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |